Optimizing dose infusion of 0.125% bupivacaine for continuous femoral nerve block after total knee replacement by Park, Chang Kil et al.
Korean J Anesthesiol 2010 May; 58(5): 468-476 
DOI: 10.4097/kjae.2010.58.5.468  Clinical Research Article
Copyright ⓒ Korean Society of Anesthesiologists, 2010 www.ekja.org
Background:  The optimal dose infusion of 0.125% bupivacaine via a femoral catheter after total knee replacement 
(TKR) has not been defined. This study examined various dose infusions of bupivacaine to determine the analgesic 
quality in patients receiving a continuous femoral nerve block (CFNB).
Methods:  Patients were randomized to receive a single-injection femoral nerve block (SFNB) or CFNB performed 
with 20 ml of 0.125% bupivacaine, followed by a continuous infusion of 0.125% bupivacaine in four groups (n = 20 per 
group): 1) 0 ml/h (SFNB), 2) 2 ml/h, 3) 4 ml/h, and 4) 6 ml/h.  The pain intensity at rest and on knee movement was 
assessed using a visual analog scale (VAS) for the first 2 postoperative days. The cumulative bolus use of IV patient-
controlled analgesia (PCA) with a morphine-ketorolac combination was evaluated.
Results:  A lower cumulative bolus of IV PCA was noted in all CFNB groups compared to SFNB on postoperative days 
(PODs) 1 and 2, respectively (P < 0.05).  Lower VAS scores at rest were observed in the 4 ml/h and 6 ml/h groups than 
in the SFNB group on PODs 1 and 2, respectively, but only on POD 2 in the 2 ml/h group (P < 0.05).  Lower VAS scores 
on movement were noted in the 4 ml/h than the SFNB group on PODs 1 and 2, but only on POD 1 in 6 ml/h (P < 0.05). 
Conclusions:  The minimum effective infusion rate of 0.125% bupivacaine for CFNB after TKR appears to be 4 ml/h 
according to the VAS pain scores.  (Korean J Anesthesiol 2010; 58: 468-476)
Key Words:  Femoral nerve block, Patient-controlled analgesia, Visual analog scale.
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Introduction
    A total knee replacement (TKR) is associated with marked 
and prolonged postoperative pain. Recently, single-dose 
and continuous peripheral nerve techniques that block the 
femoral nerve have been used [1,2]. However, a continuous 
femoral nerve block (CFNB) leads to the administration of large 
volumes of bupivacaine with the potential risk of toxicity caused 
by the accumulation of the drug after prolonged periods of 
infusion [3]. Therefore, “dose-sparing” infusion techniques are 
needed. The reported infusion rates of 0.125% bupivacaine that 
provide effective analgesia vary from 6 [4] to 10 [5] or 12 ml/h [3]. 
However, lower infusion rates of bupivacaine for FNB in terms 
of analgesia have not been evaluated, leaving unanswered 469 www.ekja.org
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the question of whether decreasing the infusion rates will still 
provide adequate analgesia. 
    CFNB may be beneficial compared to single-injection femoral 
nerve block (SFNB) because previous studies reported that the 
duration of the analgesic effect from a SFNB is typically 8 to 
24 h [1,6], whereas severe pain after TKR, particularly during 
physical therapy, may persist through the second day after 
surgery [7]. 
    CFNB is the standard treatment for postoperative pain after 
TKR at our institution. To date, an optimal dose infusion of 
0.125% bupivacaine via a femoral catheter after TKR has not 
been defined. This study examined the minimum effective 
infusion rate of 0.125% bupivacaine (2, 4, and 6 ml/h) for 
CFNB. The primary aims were the analgesic efficacy, systemic 
opioid analgesic consumption, and treatment-related side 
effects among the various doses of femoral infusion used. 
The secondary aim was to compare the effects of SFNB versus 
CFNB.
Materials and Methods
    After gaining approval of the Institutional Ethics Committee 
and written informed consent, 88 ASA physical status I or 
II female patients scheduled to undergo elective unilateral 
TKR under spinal anesthesia (SA) were enrolled in this study. 
Patients who had undergone surgery in the morning were 
included. There were no male patients during the study period. 
Patients were excluded if they met any of the following criteria: 
contraindications to a regional anesthetic technique (e.g., 
local infection, sepsis, coagulation abnormality), allergy to 
local anesthetic or morphine, contraindications for NSAID 
use, preexisting neurological deficit in the lower extremities, 
and inability to comprehend the pain scales or use IV patient-
controlled analgesia (PCA) device. After surgery in the 
postanesthesia care unit (PACU), all patients were given an 
explanation of the visual analog scale (VAS) and were also 
familiarized with the use of IV PCA. There were no significant 
differences between the study groups in terms of age, weight, 
height, anesthetic time and operating time (Table 1). In the 
anesthetic time, the duration for FNB or femoral catheterization 
was included.
    Patients were randomized to receive SFNB (control group) 
with 20 ml of 0.25% bupivacaine with epinephrine 1 : 200,000 or 
CFNB performed with a bolus dose, followed by a continuous 
infusion of 0.125% bupivacaine in the following four groups 
(n = 20 per group): 1) 0 ml/h (SFNB), 2) 2 ml/h, 3) 4 ml/h, and 
4) 6 ml/h. This prospective study was designed to evaluate the 
analgesic efficacy and side effect profile of various infusions of 
0.125% bupivacaine during CFNB compared to SFNB after TKR. 
Premedication consisted of 1-2 mg of IV midazolam. 
    In the patients randomized to SFNB, the femoral blocks were 
performed before the induction of SA by one investigator ex-
perienced in these techniques. With patients in the supine 
position, the puncture site was located 1-2 cm below the 
inguinal crease and 1.5-2.0 cm lateral to the femoral artery. 
The femoral nerve was identified using a nerve stimulator (In-
ner  vator
Ⓡ, Fisher&Paykel, New Zealand) via a 50-mm, 22-gauge 
insulated needle (Stimuplex
Ⓡ; B. Braun, Melsungen, Germany) 
for precise nerve location. With an initial output of 2 mA, the 
block needle was advanced cephalad in the sagittal plane at 
an angle of 30
o to the skin until quadriceps femoris muscle 
contractions were elicited. The position was then judged 
adequate when an output of ≤0.4 mA at a frequency of 1 Hz still 
elicited contractions of the quadriceps. After negative aspiration 
for blood, 20 ml of the local anesthetic solution was injected 
over a 2-min period. SA was performed immediately after the 
procedure was accomplished. 
    In the patients randomized to CFNB, a femoral catheter was 
placed before inducing SA by one investigator. The femoral 
nerve was located accurately with an 18 gauge short-beveled 
cannula (Contiplex
Ⓡ set; B. Braun, Melsungen, Germany) 
using the same method described for the single-injection 
technique. Ten ml of normal saline were injected in the sheath 
before introducing the catheter and a 20-gauge catheter was 
threaded 10-15 cm in a cephalad direction from the skin. The 
femoral catheters were tunneled 5 cm subcutaneously and 
laterally, after which the catheters were secured to the skin with 
a catheter-locking device (AceLock, Acemedical, Korea), which 
Table 1. Demographic and Perioperative Data
0 ml/h
 (n = 20) 
2 ml/h
 (n = 20) 
4 ml/h
 (n = 20) 
6 ml/h
 (n = 20) 
Age (yr)
Sex (M/F)
Weight (kg)
Height (cm)
Operating time (min)
Anesthetic time (min)
Bupivacaine (mg per 2 days)
68.1 ± 4.9
   0/20
59.9 ± 8.5
150.3 ± 6.4
  84.8 ± 19.6
138.8 ± 26.8
  -
67.5 ± 6.7
   0/20
57.6 ± 9.1
151.0 ± 6.0
  88.5 ± 17.6
146.3 ± 31.7
137.6 ± 9.6
67.5 ± 6.2
   0/20
  63.2 ± 11.6
150.8 ± 7.4
  96.3 ± 14.7
149.5 ± 22.6
271.9 ± 23.5
  66.7 ± 7.3
   0/20
  62.5 ± 11.0
150.8 ± 6.1
  85.9 ± 21.3
150.6 ± 31.2
413.4 ± 21.4
Values are mean ± SD except gender. There are no significant differences among the groups except bupivacaine doses.470 www.ekja.org
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was then covered with a transparent plastic cover (Ioban
TM 2, 
3M Health Care, USA). Approximately 2-3 ml of normal saline 
was injected through the femoral catheter to ensure patency. To 
verify the correct position of the catheter, 3 ml of contrast media 
(iopamidol) was injected via the catheter and the location of 
the catheter tip was confirmed using a C-arm fluoroscope. A 
printed paper of the pelvis revealed the zone of diffusion of the 
contrast media and the location of the catheter tip under the 
fascia. This position was qualified as medial (over the psoas 
muscle) (Fig. 1A), intermediate (Fig. 1B), or lateral (over the 
iliacus muscle) (Fig. 1C). The lumbar plexus anatomy and the 
zones reached by the spread of local anesthetic under the fascia 
iliaca were reported by Capdevila et al. (Fig. 2) [8].
    SA was performed at the L3-4 or L4-5 intervertebral space 
using a 25-gauge Quinke needle with the patient in the 
lateral position and the surgical side down. All patients were 
administered 6-8 mg of hyperbaric bupivacaine 0.5% together 
with epinephrine 0.05 mg and 0.1 mg of morphine sulfate into 
the intrathecal space. After obtaining successful SA, a bladder 
catheter was inserted and surgery was allowed to proceed. 
The procedure was performed with a tourniquet applied to 
the thigh and inflated at 300 mmHg. All surgical procedures 
were performed by the same orthopedic surgeon. No local 
anesthetics were injected through the femoral catheter during 
surgery in any of the CFNB groups. Further intraoperative 
sedation consisted of midazolam 1-2 mg.
    At the end of the operation in the CFNB groups, 20 ml of a 
local anesthetic solution was administered via the catheter. In 
the PACU, a continuous femoral infusion of 0.125% bupivacaine 
at a rate of 2, 4, and 6 ml/h, depending on the group allocation, 
was started one hour after the bolus injection, which was then 
continued into the postoperative period for 3 or 4 days. The 
amount of postoperative bupivacaine received by each patient 
in the first 2 days was noted and the femoral catheters were 
removed on the 3
rd or 4
th postoperative day (POD). A sensory 
block using a pinprick test with a blunt needle on the anterior, 
medial and lateral aspect in the middle third of the thigh were 
assessed twice daily by an independent observer. This was 
confirmed by a lack of or reduced sensation involving the each 
aspect compared to the same stimulation in the contralateral 
thigh. The loss of sensation was assessed around the middle 
third of the thigh in each aspect, but not around the knee 
because of the presence of extensive dressings around the knee 
after surgery. A pinprick test in the PACU was performed upon 
Fig. 1. Frontal radiographs of the pelvic region show the location of the catheter tip (arrows) and the spread of the 3 ml of contrast media. (A) 
The tip is located under the iliac fascia covering the psoas major muscle (medial). (B) The tip of the catheter is located between the medial and 
lateral position (intermediate). (C) The tip is located under the iliac fascia covering the iliacus muscle (lateral).
Fig. 2. This figure shows the zones reached by the spread of the local 
anesthetic under the fascia iliaca. (A) Internal spread under the 
psoas muscle fascia. (B) External spread under the iliacus muscle 
fascia. (C) Spread to the roots of the lumbar plexus. 1 = lateral 
femoral cutaneous nerve, 2 = femoral nerve, 3 = obturator nerve 
(Reprinted from Capdevila et al.’s study [8]).471 www.ekja.org
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resolution of the spinal anesthetic. 
    In the PACU, the patients were provided with a IV PCA device 
(Accumate 1000
Ⓡ, Woo Young Medical, Korea) containing 
0.5 mg/ml morphine plus 1.5 mg/ml ketorolac. The PCA 
system was set at a bolus of 1 ml of the morphine-ketorolac 
solution on demand, with an 8-min lockout interval and no 
continuous background infusion. The patient was then asked 
to press the button whenever she was in pain at a VAS scale of 
>30 out of 100. The cumulative bolus use of IV PCA (ml) was 
recorded from the electronic memory of the PCA machine at 
the measurement times for the first 2 days. The pain intensity 
at rest and with a standardized motion of the knee (30
o of 
passive flexion) was assessed by the patients using a VAS (0 = 
no pain and 100 = worst pain) in the PACU, at 6 PM on the day 
of surgery, and at 9 AM and 6 PM on POD 1 and 2, respectively. 
The patients received rescue doses of 90 mg of diclofenac 
IM when dissatisfied with the IV PCA. The rescue doses of 
diclofenac were recorded at each measuring interval for the first 
2 days. 
    The presence and severity of nausea was assessed using an 
ordinal scale (0 = no nausea; 1 = mild; 2 = moderate; 3 = severe). 
Ten mg metoclopramide IV and 8 mg ondansetron IV were 
prescribed routinely to all patients as antiemetic medication 
upon arrival to the ward and for the first 2 days. The treatment 
for pruritus consisted of IM chlorpheniramine 4 mg, and 
treatment in all cases was initiated upon the patient’s request. 
    All patients were monitored for respiratory depression by an 
assessment of the respiratory rate. The respiratory rates were 
assessed by the study anesthesiologist at the measurement 
times and by the ward nurses every 4 h. A respiratory rate <10 
breaths/min was considered to be respiratory depression and 
was treated systematically with incremental doses of naloxone 
as required. Supplemental oxygen was not used routinely. 
However, oxygen 3 L/min was administered via a nasal cannula 
if at any time their respiratory rate was <10 breaths/min. 
    The degree of patient sedation was graded on a 4-point scale: 
0 = alert; 1 = drowsy; 2 = sleeping, easy to arouse; and 3 = 
sleeping, difficult to arouse. Significant sedation was defined as 
a sedation score of 3. Urinary retention could not be assessed 
because indwelling catheters in the urinary bladder were 
left in place for approximately 24 hours postoperatively. All 
data was collected by an anesthesiologist not involved in the 
administration of anesthesia or in patient care in the PACU. 
    Statistical analysis was performed using SPSS software 
(version 12.0, USA). A one-way ANOVA test was performed to 
compare the patient’s age, weight and height, anesthetic time 
and operating time, and Dunett test was used as a post hoc 
test. One-way ANOVA and a Dunett test as a post hoc test was 
used to compare the PCA bolus use and VAS pain scores. A chi-
squared test was used to compare the location of the catheter 
tip, sensory block, side effects and rescue medications. For all 
statistical analyses, a P value < 0.05 was considered significant.
Results
    Of the 88 patients enrolled, 8 were excluded from data 
analysis for the following reasons: three patients had failed FNB 
despite successful identification of the femoral nerve with a 
nerve stimulator; one patient experienced a dislodged femoral 
catheter on POD 1; one patient frequently used demand 
doses for pain at a site other than the operated knee because 
patients undergoing knee replacement surgery frequently have 
a polyarticular affliction; one patient frequently pressed the 
demand button due to anxiety and not for pain; one patient 
showed postoperative delirium on POD 1; and one patient 
showed inadequate SA. Including the results from these eight 
patients would have masked the overall effect of the FNB. 
If a patient was removed from the trial, the same trial was 
performed on another patient. A final total of 80 patients were 
distributed equally among the groups.
    The location of the catheter tip was verified by a C-arm after 
catheterization in all CFNB patients. Of 60 patients receiving 
a femoral catheter, 6 could not obtain printed paper due to 
a failure of the printer. Therefore, only 54 could have printed 
paper of the pelvic region. Of these, 3 catheters, one each in 2, 
4, and 6 ml/h, showed coiling in the femoral head area, even 
though the length inserted was 10-15 cm. Fortunately, the 
FNB occurred in one each in 4 and 6 ml/h. Unfortunately, the 
block was considered to have failed in one in the 2 ml/h group. 
Subsequently, the femoral catheter was reinserted with a nerve 
stimulator in the PACU for the patient, and the success of the 
femoral block after the bolus injection was confirmed. These 
3 patients were excluded from data analysis for the catheter 
tip location. Table 2 lists the location of the catheter tip under 
the fascia in the remaining 51 cases. There were no significant 
differences in the position of the catheter tip between the CFNB 
groups. 
    The decreased cumulative bolus use of IV PCA was observed 
in all CFNB groups compared to the control (0 ml/h, SFNB) 
beginning 6 PM on POD 1 through to 6 PM on POD 2, respec-
Table 2. Location of the Femoral Catheter Tip Under the Fascia Iliaca 
in the Three Groups
2 ml/h
 (n = 16) 
4 ml/h
 (n = 17) 
6 ml/h
 (n = 18) 
Medial
Intermediate
Lateral
4 (25.0)
6 (37.5)
6 (37.5)
5 (29.4)
5 (29.4)
7 (41.2)
5 (27.8)
5 (27.8)
8 (44.4)
Data are number (%) of patients. There are no significant differences 
among the groups.472 www.ekja.org
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tively (P < 0.05) (Fig. 3). The resting VAS scores were signi-
ficantly lower in the 4 ml/h and 6 ml/h groups compared to the 
control on PODs 1 and 2, respectively, but only on POD 2 in the 
2 ml/h group (P < 0.05) (Fig. 4). Lower VAS scores on movement 
were observed in the 4 ml/h group compared to the control on 
PODs 1 and 2, but only on POD 1 in the 6 ml/h group (P <0.05) 
(Fig. 5). Overall, the bolus use of IV PCA, and the VAS pain 
scores during rest and activity were similar in the groups on the 
day of surgery (Fig. 3-5).
    Although, all CFNB groups used lower IV PCA doses than the 
control, it is believed that the minimum effective infusion rate 
of 0.125% bupivacaine would be 4 ml/h according to the VAS 
scores. Analgesia is not further improved by increasing the 
infusion rate to 6 ml/h. The infusion rate of 2 ml/h provided 
ineffective analgesia compared to the other two CFNB groups.
    Table 3 shows sensory block on the anterior, medial, lateral 
and all 3 aspects of the thigh over time. The sensory block in 
the control (SFNB) was compared with those in the other three 
Fig. 3. This diagram compares the cumulative postoperative 
consumption of IV PCA (ml) by patients in the four groups during the 
first postoperative 2 days. All CFNB groups show lower cumulative 
PCA bolus use of morphine plus ketorolac than the control on PODs 
1 and 2, respectively. PCA: patient-controlled analgesia, CFNB: 
continuous femoral nerve block, PACU: postanesthesia care unit, 
POD: postoperative day. *P < 0.05 compared to the 0 ml/h group.
Fig. 4. This diagram compares the VAS pain scores at rest in the 
four groups. The VAS scores at rest are significantly lower in the 
4 ml/h and 6 ml/h groups than the control on PODs 1 and 2, 
respectively, but only on POD 2 in 2 ml/h. VAS: visual analog scale, 
PACU: postanesthesia care unit, POD: postoperative day. *P < 0.05 
compared to the 0 ml/h group.
Fig. 5. This diagram compares the VAS pain scores on movement in 
the four groups. The VAS scores on movement in the 4 ml/h group 
are significantly lower than the control on PODs 1 and 2, but only 
on POD 1 in 6 ml/h. VAS: visual analog scale, PACU: postanesthesia 
care unit, POD: postoperative day. *P < 0.05 compared to the 0 ml/h 
group.
Table 3. Partial or Complete Sensory Loss to Pinprick on the Three 
Aspects in the Middle Third of the Thigh in the Four Groups
0 ml/h
 (n = 20) 
2 ml/h
 (n = 20) 
4 ml/h
 (n = 20) 
6 ml/h
 (n = 20) 
Anterior aspect
    POD 0 PM
    POD 1 PM
    POD 2 PM
Medial aspect
    POD 0 PM
    POD 1 PM
    POD 2 PM
Lateral aspect
    POD 0 PM
    POD 1 PM
    POD 2 PM
All 3 aspects
    POD 0 PM
    POD 1 PM
    POD 2 PM
70
-
-
85
-
-
55
-
-
45
-
-
85
80
60
85
70
65
75
55
55
75
45
45
95
95
80
95
85
80
85
85
60
75
75
45
100*
90
85
95
80
75
  90*
80
70
  85*
65
50
Data are percentage of patients. POD: postoperative day. *P < 0.05 
compared with 0 ml/h.473 www.ekja.org
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CFNB groups only at 6 PM on the day of surgery (POD 0), but 
not on PODs 1 and 2 because the sensory block in the control 
had mostly dissipated on PODs 1 and 2. There was a significant 
difference in sensory block on the anterior and lateral aspects 
of the thigh between the control and 6 ml/h groups at 6 PM on 
the day of surgery (P < 0.05). However, there was no significant 
difference in sensory block on each aspect of the thigh between 
the 2 ml/h and the other two CFNB groups during the study. 
In all 3 aspects of the thigh, there was a significant difference 
between control and 6 ml/h at 6 PM on the day of surgery (P 
< 0.05), but no significant difference between the 2 ml/h and 
other two CFNB groups during the study. The sensory block in 
the SFNB had mostly dissipated by 9 AM on POD 1. At 9 AM 
on POD 1, only 20% of patients in SFNB still showed sensory 
evidence of a FNB (data not shown) but no patient in SFNB 
showed any sensory evidence of a FNB by 6 PM on POD 1. The 
sensory block in all CFNB groups had dissipated over time. 
Although not verified, the regression of sensory block was 
faster in the 2 ml/h than the other two CFNB groups. No patient 
showed clinical evidence of local anesthetic toxicity.
    Overall, the incidence of PONV, pruritus and rescue analgesics 
were similar in the control and all CFNB groups (Table 4). 
The incidence of a sedation score = 1 was significantly more 
frequent in the 6 ml/h group than in the control group (P < 0.05) 
(Table 4). No patient had a sedation score ≥2, and no significant 
sedation was observed in any of the patients. There was no 
patient with respiratory rate <10 breaths/min. No patient 
required additional oxygen in the ward. Consequently, no 
patient showed evidence of respiratory depression.
Discussion
    To our knowledge, this is the first study in which the minimum 
effective infusion rate of 0.125% bupivacaine for CFNB in 
terms of the VAS pain scores appears to be 4 ml/h after 
TKR. We expected better analgesia with a high infusion rate 
of bupivacaine but analgesia was not improved further by 
increasing the infusion rate up to 6 ml/h. There may be two 
explanations for this observation. Firstly, there is no anatomical 
fascial sheath capable of conveying a local anesthetic solution 
or a catheter from below the inguinal ligament to the lumbar 
plexus [9]. Therefore, the spread of local anesthetic to the three 
nerves (the femoral, obturator, and lateral femoral cutaneous 
nerves) is difficult to achieve even in sufficient quantities. 
Secondly, the dose range of the infusion rate from 4 to 6 ml/
h used in this study was probably too small to allow any 
meaningful comparisons of the VAS pain scores. Van der Elst 
et al. [10] reported that a 3-in-1 block provides similar good 
pain relief with a continuous infusion rate of 10 ml/h to that of 
15 ml/h after a total hip replacement. They further stated that 
neither the extent of anesthesia nor the quality of analgesia 
is improved by increasing the infusion rate or by adding PCA 
boluses. However, further studies will be needed to determine 
if there is any difference in analgesic efficacy of continuous 
femoral block between low (4 ml/h as in our study) and high (10 
ml/h as in Van der Elst et al.’s study [10]) infusion rates of  0.125% 
bupivacaine. On the other hand, 2 ml/h provided inadequate 
pain relief compared to the other two CFNB groups. Hence, 
2 ml/h is considered too low to spread under the fascia for a 
multiple nerve blockade. 
    Overall, the VAS pain scores during rest and activity, and 
the bolus use of IV PCA were similar in the groups on the day 
of surgery. This might be explained by the fact that significant 
analgesia might have been achieved in part with IT morphine. 
Therefore, no meaningful comparisons of the VAS pain scores 
and the bolus use of IV PCA in the groups could be obtained on 
the day of surgery. The other contributing factor would be that 
the SA provided preemptive analgesia [11]. Overall, all patients 
had excellent pain relief on the day of surgery.
    Local anesthetic accumulation and toxicity is a potential 
problem with the continuous FNB technique. Esteve et al. 
[3] used a bolus dose of 2.5 mg/kg of 0.5% bupivacaine with 
epinephrine followed by the continuous infusion of 0.125% 
bupivacaine at 12 ml/h without epinephrine during 48 hours. 
In their study, the mean plasma bupivacaine level was 1.78 ± 
0.59 μg/ml, and no neurological complications were recorded. 
The reported toxic concentration of bupivacaine is 2 μg/ml 
[12]. The bolus dose and infusion rate of 4 ml/h in the present 
study was one third of those reported by Esteve et al. Although 
the bupivacaine levels were not measured during CFNB, it is 
believed that a rate of 4 ml/h would be a safe dose in terms of 
local anesthetic toxicity. 
    The pain intensity and opioid consumption are routine 
measures of the outcome. However, opioid consumption 
probably is not a very reliable index for assessing the level 
of analgesia because there is no convincing evidence for 
Table 4. Incidence of Nausea, Vomiting, Pruritus, Sedation and Res-
cue Medicine
0 ml/h
 (n = 20) 
2 ml/h
 (n = 20) 
4 ml/h
 (n = 20) 
6 ml/h
 (n = 20) 
Nausea score       0
                                  1
                                  2
                                  3
Vomiting
Pruritus
Rescue antipruritics
Rescue analgesics
Sedation score = 1
  7 (35)
   5 (25)
  5 (25)
  3 (15)
  9 (45)
15 (75)
13 (65)
14 (70)
1 (5)
  6 (30)
  7 (35)
  4 (20)
  3 (15)
  7 (35)
18 (90)
12 (60)
17 (85)
1 (5)
  8 (40)
  8 (40)
  2 (10)
  2 (10)
  7 (35)
14 (70)
    5 (25)*
13 (65)
  5 (25)
  8 (40)
  4 (20)
  5 (25)
  3 (15)
10 (50)
17 (85)
10 (50)
14 (70)
     7 (35)*
Data are number (%) of patients.  *P < 0.05 compared with 0 ml/h.474 www.ekja.org
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proportionality between the postoperative pain intensity 
and analgesic requirements [13]. These results show that 
the cumulative bolus doses of IV PCA consumed in all 
CFNB groups were lower than that in the SFNB group. This 
suggests that all CFNB groups are more effective in analgesia 
than SFNB. However, considering the VAS, 4 ml/h appears 
to be superior to 2 ml/h, whereas 6 ml/h does not provide 
any added advantage. Therefore, a larger volume (6 ml/h) 
provides no additional benefit and a smaller volume (2 ml/
h) is less effective. It is believed that the VAS scores would be 
more sensitive in capturing the differences in pain during 
periods of intense stimulation. The obvious downside to using 
morphine consumption as a marker of pain is that patients are 
unwilling to use of morphine due to nausea, or patients may 
use morphine for other reasons besides pain [14]. In the present 
study, some patients were concerned about the possible nausea 
and delayed wound healing because of the use of IV PCA, and 
were unwilling to demand a dose frequently enough to achieve 
satisfactory pain control. To review the data, the number of 
patients who were reluctant to use IV PCA because of nausea 
was 4 in 0 ml/h, 3 in 2 ml/h, 1 in 4 ml/h and none in 6 ml/h.
    Overall, SFNB had greater VAS scores than the CFNB groups 
despite the higher cumulative bolus use of IV PCA than in the 
CFNB groups. It was believed that the higher cumulative bolus 
use of IV PCA may be associated with adequate pain relief in 
SFNB but this did not occur. It is possible that the use of IV PCA 
by the patient was not adequate or the bolus dose of 0.5 mg 
morphine was too small and an 8 min lockout was too long to 
alleviate severe surgical pain. The adequate demand dose of 
morphine for PCA is controversial. Owen et al. [15] indicated 
that a bolus dose size of 0.5 mg morphine was inadequate for 
many patients, whereas 2 mg was often too large, and a dose of 
1 mg morphine was optimal. However, it was expected that the 
bolus dose of morphine could be reduced from 1 mg to 0.5 mg 
for adequate analgesia when combined with ketorolac. Indeed, 
Picard et al. [16] reported that a combination of half-doses 
of morphine (0.5 mg/ml) and ketorolac (1.5 mg/ml) is more 
effective in controlling postoperative pain than morphine (1 
mg/ml) or ketorolac (3 mg/ml) alone. 
    As expected, a sensory block to a pinprick from SFNB had 
mostly dissipated by 9 AM on POD 1. However, severe posto-
perative pain after TKR persisted for more than 2 days [17], and 
SFNB is inadequate for pain relief after TKR. This is consistent 
with the findings of Fournier et al. [18] in which for a longer 
term pain relief, a single shot technique FNB appeared to be 
inadequate. 
    Three catheters showed coiling in the femoral head area, even 
though the length inserted had been 10-15 cm. Therefore, the 
length of insertion is a poor indicator of location of the catheter. 
In one patient who showed catheter-coiling with a failed block, 
the catheter had been inserted when a sartorius muscle twitch 
was elicited. In that patient, another femoral catheter was 
reinserted using a nerve stimulator in the PACU. 
    The distribution of the sensory block depends on the location 
of the catheter tip under the fascia iliaca [19]. A comparison of 
the different femoral infusion rates of bupivacaine administered 
by femoral catheters is possible only if the position of the 
catheter tip can be verified to avoid methodological bias in data 
analysis [19]. These clinical findings show that the course of the 
catheter under the fascia was unpredictable. Although only 51 
patients were analyzed in this study, the location of the catheter 
under the fascia was similar in the infusion groups. Therefore, it 
is believed that the position of the catheter tip among the CFNB 
groups would not affect the results.
    The method for assessing a sensory block in the cutaneous 
distribution of the obturator nerve is controversial. The 
cutaneous distribution of the obturator and femoral nerve in 
the medial aspect of the thigh cannot be distinguished by a 
pinprick test. Recently, Bouaziz et al. [20] reported that the only 
way to effectively evaluate the obturator nerve function is to 
assess the adductor strength. Furthermore, Macalou et al. [21] 
stated that an assessment of the obturator nerve block only 
based on a cutaneous blockade should be considered obsolete. 
Unfortunately, this study did not assess the adductor strength 
for an obturator nerve block. Therefore, Table 3 in this study 
presented a sensory block on the anterior, medial, and lateral 
aspects, instead of a sensory block in the cutaneous distribution 
of the femoral, obturator, and lateral femoral cutaneous nerves. 
    In this study, epinephrine 5 μg/ml (1 : 200,000) was added 
to 0.25% bupivacaine as a loading dose for FNB. Epinephrine 
is used with local anesthetics for two reasons. It slows the 
absorption of local anesthetic, thereby resulting in more 
profound analgesia with a longer duration. Perhaps more 
importantly, epinephrine, by reducing the rate of absorption, 
also reduces the blood levels of local anesthetic drugs [22]. 
Bupivacaine increases the skin blood flow after an intradermal 
injection in human skin, producing vasodilatation [23,24]. 
Epinephrine has a vasoconstrictor effect when coinjected with 
clinical doses of bupivacaine [24]. Therefore, it increases the 
duration of dermal analgesia of bupivacaine [23]. Epinephrine 
may also increase the sensory block and improve the pain-
relieving effect of a mixture of bupivacaine and fentanyl infused 
epidurally at a thoracic level after major thoracic or abdominal 
surgery [25]. In contrast, Misra et al. [26] demonstrated that 
the addition of epinephrine 5 μg/ml to bupivacaine did not 
affect significantly the duration of postoperative analgesia after 
combined femoral 3-in-1 and sciatic nerve blocks in patients 
undergoing TKR under SA. However, they did not assess the 
pain intensity at rest or on movement. Therefore, the quality 
of pain relief when adding epinephrine to bupivacaine could 475 www.ekja.org
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not be determined. To evaluate the time taken for return of 
sensation from femoral 3-in-1 block, they assessed the sensory 
block only at the lateral part of the thigh, not at the three 
aspects of thigh (the anterior, medial and lateral). Furthermore, 
they noted that some patients experienced pain at the site 
of the surgery before the complete return of sensation in the 
representative areas tested. They measured the mean time 
to first analgesia in all 22 patients but five of them received 
opioids for pain in areas other than the operated knee, thereby 
confounding the results. Therefore, further study is needed to 
evaluate the effect of epinephrine added to bupivacaine during 
femoral infusion to provide postoperative pain relief in patients 
undergoing TKR.
    There were several limitations in this study. First, this 
study did not include patients who had received doses >6 
ml/h of 0.125% bupivacaine. A future study will be needed 
to determine if there is any benefit of larger infusion rates 
compared to 4 ml/h. Secondly, the insertion of femoral 
catheters into patients in SFNB and the infusion of saline into 
the catheter, as would be required for a truly blinded study, 
were considered inappropriately invasive and unethical. 
Therefore, no sham catheter infusion was performed. Thirdly, 
in patients randomized to SFNB, the local anesthetic solution 
was injected immediately before the induction of SA, but was 
injected after surgery in those patients randomized to CFNB. 
The local anesthetic solution should have been injected after 
surgery in patients randomized to the control in the same 
manner as in those randomized to CFNB. This study suggested 
that performing a SFNB after surgery would have been more 
beneficial for prolonged postoperative analgesia. However, it 
was difficult to find the patella twitch with a nerve stimulator 
when there are extensive dressings around the knee after 
surgery. Finally, the incidence of a successful block in SFNB is 
unknown because the sensory function was not assessed before 
SA due to the busy operating room. This study relied on nerve 
stimulator guidance and evidence of muscle contraction to 
indicate the block accuracy. 
    In conclusion, the minimum effective infusion rate of 0.125% 
bupivacaine for CFNB after TKR would be 4 ml/h. Analgesia 
was not improved further by increasing the infusion rate to 6 
ml/h. 
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